US 2012/0071409 A1Published application

Colloidal Liposomal Compositions and Methods

OwnerJacob C. Hack, Richard D. Tobias +5inventors

InventorsJacob C. Hack, Richard D. Tobias, Kenneth Blum, B. William Downs, Roger L. Waite, William J. Heaney, John J. Giordano

Life of this patent

Estimating the term…

patentgrep

Loading patent…

Abstract

A formulation delivery system is disclosed. When configured as a pro-liposome oral tablet, the tablet comprises a blend of at least one Iiposome forming ingredient, at least one active ingredient and at least one co-disintegrant. After ingestion at least a portion of the tablet disintegrates in a portion of an alimentary system to provide one or more in situ Iiposome encapsulated active ingredients. A method of producing the pro-liposome oral tablet and a method of therapeutically dosing with the pro-liposome oral tablet are further disclosed. The formulation delivery system may be configured as any one of a pro-liposome oral tablet, sublingual tablet, caplet, capsule and aerosol.

Claims5

Dependent claims

A composition comprising, in combination:

a. a pre-formed, pro-liposome delivery system selected from the group consisting of an oral tablet, a sublingual tablet, a caplet, a capsule, and an aerosol, wherein the pre-formed, pro-liposome delivery system comprises at least one liposome forming ingredient member and at least two chemically distinct disintegrating agents;
b. a biologically active homeopathic active ingredient dispersed in the pre-formed, pro-liposome delivery system;
wherein after ingestion of the composition the pre-formed, pro-liposome delivery system disintegrates in a patient's alimentary and at least a portion of the at least one liposome forming ingredient member encapsulates in in situ-formed liposomes at least a portion of the biologically active homeopathic active ingredient.

Dependencies are inferred from the claim text.

Facts

Application: 13/043,442Filed 8 Mar 2011
Priority: 18 Apr 2007
Published: 22 Mar 2012
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

A61K 38/27
Hormones: growth hormone [GH], i.e. somatotropin
A23L 33/10
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof: using additives
A61K 9/1277
Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant: preparation processes;…
A61K 9/2013
Excipients; Inactive ingredients: organic compounds, e.g. phospholipids, fats